Zetia Ezetimibe

Zetia is a prescription medication used to lower cholesterol levels in the blood. It contains the active ingredient ezetimibe, which works by inhibiting the absorption of cholesterol from the intestines, leading to reduced cholesterol levels in the bloodstream. Originally developed by Schering-Plough Corporation, the brand was acquired by Merck & Co., Inc. in 2009, making Merck the current owner of the Zetia brand. Ezetimibe is manufactured in multiple countries, including the United States, to meet global demand. The product is available in various strengths and formulations, including 10 mg tablets, and is commonly prescribed alongside other cholesterol-lowering medications to enhance therapeutic efficacy.